GW Pharmaceuticals OverviewGW Pharmaceuticals EBIT
EBIT (Earnings Before Interest and Taxes) analysis for GWPH.
Quarterly EBIT
-$21.03M
↓ 192.33% YoY
As of Mar 31, 2021
Annual EBIT (TTM)
-$65.60M
↑ 11.69% YoY
Trailing 12 months ending Mar 31, 2021
GW Pharmaceuticals OverviewEBIT (Earnings Before Interest and Taxes) analysis for GWPH.
As of Mar 31, 2021
Trailing 12 months ending Mar 31, 2021